The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
about
Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial.LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux.LINX®, a novel treatment for patients with refractory asthma complicated by gastroesophageal reflux disease: a case report.LINX(™) Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease.Outcomes of esophageal surgery, especially of the lower esophageal sphincter.Current status: new technologies for the treatment of patients with fecal incontinence.The surgeon’s perspective on oesophageal disease, and what it means to pathologists.Refractory gastroesophageal reflux disease.Gastroesophageal reflux disease: diagnosis and patient selection.Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study.Gastroesophageal Reflux Management with the LINX® System for Gastroesophageal Reflux Disease Following Laparoscopic Sleeve Gastrectomy.Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.Regurgitation in patients with gastroesophageal reflux disease.Revaluation of the efficacy of magnetic sphincter augmentation for treating gastroesophageal reflux disease.Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux disease.The Esophageal Sphincter Device for Treatment of GERD.Sleeve gastrectomy and anti-reflux procedures.Magnetic lower esophageal sphincter augmentation device removal.Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease.Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease.Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation.Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias.2014 SSAT State-of-the-Art Conference: advances in diagnosis and management of gastroesophageal reflux disease.Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges.Hiatal hernia recurrence following magnetic sphincter augmentation and posterior cruroplasty: intermediate-term outcomes.Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease.SAGES technology and value assessment committee (TAVAC) safety and effectiveness analysis: LINX® reflux management system.Endoluminal perforation of a magnetic antireflux device.Magnetic Sphincter Augmentation for Gastroesophageal Reflux at 5 Years: Final Results of a Pilot Study Show Long-Term Acid Reduction and Symptom Improvement.Crural Closure improves Outcomes of Magnetic Sphincter Augmentation in GERD patients with Hiatal Hernia.Selected commentary to “Esophageal sphincter device for gastroesophageal reflux disease”Spotlight on the Linx™ Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research
P2860
Q34947112-E7A58D3E-EB31-4C44-A711-4AAFA8C03A42Q36886513-DB08CFDC-B31E-4B21-92D7-1F192D34D495Q36929966-E1FF87C8-01CA-4C7A-85AD-62B940817B90Q38067129-3FB28AA9-297F-4AF1-AC1F-B9EBAD6E6C34Q38151801-0D192E93-359C-4C06-A41C-B4857DBF6C28Q38194462-FFAC0D81-8593-42E9-870A-564D31B2CAF7Q38237038-23E908F3-883C-4855-A0A9-99561EBE587CQ38255997-D0E61C60-0DD5-4EA9-BB9C-74AE3E68232AQ38329753-7AA6423B-524C-4EAA-8CDC-040861B3DC54Q38424408-730DA85A-65CA-417F-881D-CF5BE4F188A0Q38545047-B4922B51-F5E2-412D-9493-B48AD9DABB92Q38599609-8BCBC2B7-C340-475B-A11F-B96ACC50A2DCQ38618005-9FDAE7E6-A854-4E49-9F92-599FEA4DA4EFQ38667098-8C45862E-9A2A-4F74-860C-706C091CBF50Q38701022-707161B0-CC61-4955-8CCB-9E27D531FCABQ38832925-4D0DB515-1334-4B0A-8932-8298532F572CQ38903760-80508D2A-E7BA-48ED-B8A3-E67376BC44DFQ39145453-19EB83B3-B8BA-4B8D-9284-C77630258D22Q39181093-614408E6-A287-4F00-A420-25D5385171D3Q44365534-260D0592-781D-4084-8039-BBF039A37EE5Q47631542-E3516D66-E7B3-4371-99C2-F06E1072AB9CQ47670014-795F615C-9D2F-41D5-B9F6-C25337908B75Q48055864-5D49A8CB-2D26-48C9-B2BC-C3BD5C9ADD53Q49829605-FF139B27-74C7-44D9-8F7E-7A9D6F564BB8Q50014007-019F12B8-95A1-4885-BAC6-68DE260374EAQ52605780-AE18F407-DD39-4852-BCC9-3E7064E81F4BQ53095816-7A81B7E5-9D44-4230-98F1-04FDE7AC9098Q53261928-E9236DEB-7E39-4B55-BCB7-3346811977DAQ53666202-C2821B3A-0F2D-47C9-B3AA-CA1889414517Q55392546-1A336A66-D128-4BA6-98BE-1685B7762488Q57546173-07885B55-8E76-4199-9663-B4378534C456Q58781538-C081F4C8-AD1F-4DE2-81F1-E622BB25D7F1
P2860
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
@en
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
@nl
type
label
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
@en
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
@nl
prefLabel
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
@en
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
@nl
P2093
P2860
P1433
P1476
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
@en
P2093
Daniel H Dunn
Greta Saino
John C Lipham
Paul Fockens
Robert A Ganz
Tom R DeMeester
Willem Bemelman
P2860
P2888
P304
P356
10.1007/S00464-012-2289-1
P407
P577
2012-04-27T00:00:00Z